Stocklytics Platform
Asset logo for symbol COEPW
Coeptis Therapeutics Holdings
COEPW4
$0.020.00%$0.02
Penny Stock
Asset logo for symbol COEPW
COEPW4

$0.02

0.00%

Performance History

Chart placeholder
Key Stats
Open$0.01
Prev. Close$0.00
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$0.00
PE Ratio-
LOWHIGH
Day Range0.01
0.02
52 Week Range0.01
0.08
Ratios
Revenue-
Earnings Growth %-
EBITDA Margin %-
EPS-

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Coeptis Therapeutics Holdings (COEPW)

Coeptis Therapeutics Holdings, Inc. (COEPW) is a company that specializes in the development of therapeutic solutions. With a focus on innovation and research, Coeptis Therapeutics aims to address unmet medical needs and improve patient outcomes. The company's mission is to discover and develop novel therapies that target a range of diseases. Coeptis Therapeutics is committed to advancing scientific understanding and translating it into effective treatments for patients around the world.
When looking at the stock price history of Coeptis Therapeutics Holdings, Inc. (COEPW), it is important to consider the company's market cap, PEG ratio, and its performance compared to the industry. These factors can provide valuable insights into the potential growth and profitability of the company. Currently, Coeptis Therapeutics has a market cap of X, indicating its overall value in the market. The PEG ratio, which compares the price-to-earnings ratio to the company's expected growth rate, can help investors assess whether the stock is over or undervalued. Furthermore, comparing Coeptis Therapeutics' stock performance to the industry can provide insight into its competitiveness and market position.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NASDAQ
add Coeptis Therapeutics Holdings to watchlist

Keep an eye on Coeptis Therapeutics Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Coeptis Therapeutics Holdings's (COEPW) price per share?

The current price per share for Coeptis Therapeutics Holdings (COEPW) is $0.02. The stock has seen a price change of $0.02 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Coeptis Therapeutics Holdings (COEPW)?

For Coeptis Therapeutics Holdings (COEPW), the 52-week high is $0.08, which is 294.09% from the current price. The 52-week low is $0.01, the current price is 84.55% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Coeptis Therapeutics Holdings (COEPW) a growth stock?

Coeptis Therapeutics Holdings (COEPW) has shown an average price growth of -4.13% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Coeptis Therapeutics Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Coeptis Therapeutics Holdings (COEPW) stock price performance year to date (YTD)?

As of the latest data, Coeptis Therapeutics Holdings (COEPW) has a year-to-date price change of -18.8%. Over the past month, the stock has experienced a price change of -30%. Over the last three months, the change has been 9.14%. Over the past six months, the figure is -8.14%.
help

Is Coeptis Therapeutics Holdings (COEPW) a profitable company?

Coeptis Therapeutics Holdings (COEPW) has a net income of -$37.57M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$34.2M. Furthermore, the EBITDA is $0.
help

What is the market capitalization of Coeptis Therapeutics Holdings (COEPW)?

Coeptis Therapeutics Holdings (COEPW) has a market capitalization of $0. The average daily trading volume is 0.02, indicating the stock's liquidity and investor engagement.

News

Take Your Investments to a Whole New Level